Andrew Zimmerman to Isothiocyanates
This is a "connection" page, showing publications Andrew Zimmerman has written about Isothiocyanates.
Connection Strength
1.825
-
Singh K, Zimmerman AW. Sulforaphane Treatment of Young Men with Autism Spectrum Disorder. CNS Neurol Disord Drug Targets. 2016; 15(5):597-601.
Score: 0.513
-
Talalay P, Zimmerman AW. Reply to Scahill: Behavioral outcome measures in autism. Proc Natl Acad Sci U S A. 2015 Jan 27; 112(4):E350.
Score: 0.480
-
Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, Zimmerman AW. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014 Oct 28; 111(43):15550-5.
Score: 0.472
-
Zimmerman AW, Singh K, Connors SL, Liu H, Panjwani AA, Lee LC, Diggins E, Foley A, Melnyk S, Singh IN, James SJ, Frye RE, Fahey JW. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Mol Autism. 2021 05 25; 12(1):38.
Score: 0.187
-
Liu H, Zimmerman AW, Singh K, Connors SL, Diggins E, Stephenson KK, Dinkova-Kostova AT, Fahey JW. Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder. Sci Rep. 2020 04 02; 10(1):5822.
Score: 0.172